Android app on Google Play

Standpoint Research Downgrades Hi Tech Pharmacal (HITK) to Hold

November 30, 2012 9:35 AM EST Send to a Friend
Get Alerts HITK Hot Sheet
Price: $43.49 --0%

Rating Summary:
    1 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade HITK Now!
Join SI Premium – FREE
Standpoint Research downgraded Hi Tech Pharmacal (NASDAQ: HITK) from Buy to Hold.

For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.

Shares of Hi Tech Pharmacal closed at $31.25 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Standpoint Research

Add Your Comment